[Skip to content]

Private Healthcare UK
Search our Site

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.


Study highlights need for new STI treatments

Health Protection Agency

A new sexual health study carried out in the UK has highlighted the need to develop new treatments for sexually-transmitted infections (STIs).

According to the Health Protection Agency (HPA), the common disease gonorrhoea is becoming increasingly resistant to many antibiotics.

This means it could become harder to treat using existing drugs - typically single doses of ceftriaxone and cefixime - in the future.

"Choosing an effective antibiotic can be a challenge because the organism that causes gonorrhoea is very versatile and develops resistance to antibiotics very quickly," explained HPA professor Catherine Ison.

She pointed out that ceftriaxone and cefixime are still very effective in treating the condition, although signs of resistance are emerging, which means new treatments or higher doses of the drugs may be necessary.

Gonorrhoea is most common among younger people. If left untreated, it can lead to more serious conditions, including pelvic inflammatory disease, ectopic pregnancy and infertility in women.

© Adfero Ltd


Sexual health news : 4 April 2010